Quote LOL, "Among the other wonderful things surrounding Phase III results being released this month. "
WHAT??????? WHAT supposed phase III clinical trial (FDA QUALITY, fully enrolled, blinded, etc) is supposedly "being released this month, LOL ???????
Name the supposed phase III trial and then show in the most recent SEC filings, from ALL of 2016, where this imaginary "phase III" clinical trial is:
1) BEING FUNDED, and with how much money in all of 2016 (R&D budget has been about a lousy $1K a month for all 2016, and THAT does not fund a phase III, LOL! )
2) Show what SEC filing shows ANY Phase III trial they've ever started, ever had that per recent SEC filings was even fully enrolled, let alone, advancing and being funded etc.
3) Per ANY RECENT SEC filing of 2016, again, name the phase III fantasy trial by name, and then tell what the total enrollment is, what it's for, and where the SEC filing describes its status in detail, as all their SEC filings (10-Q of 10-K) give a great amount on ALL their clinical trials.
Thee ONLY phase II/III trial(s) they ever had were SUSPENDED IN 2010, FOR LACK OF FUNDING, per their most recent SEC filed commentary, made in 2016. NOTHING has even been stated in any SEC filing to contradict those statements. NOR has any PR contradicted that.
The Clinicaltrials.gov site said the trial you're using as DIS-INFORMATION, it said it was "anticipated completion date" as 2010, then 2012, then I believe 2014, and then 2017. NEVER has one of those "anticipated dates" been hit yet.
SO WHICH SUPPOSED "phase III" trial is this DIS-INFORMATION referring to, PER SEC FILED FACTS or a recent "PR"?????
Market Data 
Markets 
AI
